Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Lianyungang Kangle Pharmaceutical Co., Ltd.

02 5Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FDA Audited

USA
SCOPE Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
SCOPE Summit
Not Confirmed

Zhejiang Kangle Pharmaceutical

City : Wenzhou

State :

Country/Area : China

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2025-03-14

blank

02

FDA Audited

USA
SCOPE Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
SCOPE Summit
Not Confirmed

Zhejiang Kangle Pharmaceutical

City : Lianyungang

State :

Country/Area : China

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-05-31

blank

03

FDA Audited

USA
SCOPE Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
SCOPE Summit
Not Confirmed

Zhejiang Kangle Pharmaceutical

City : Wenzhou

State :

Country/Area : China

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-03-22

blank

04

FDA Audited

USA
SCOPE Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
SCOPE Summit
Not Confirmed

Zhejiang Kangle Pharmaceutical

City : Wenzhou

State :

Country/Area : China

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2016-07-22

blank

05

FDA Audited

USA
SCOPE Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
SCOPE Summit
Not Confirmed

Zhejiang Kangle Pharmaceutical

City : Lianyungang

State :

Country/Area : China

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2016-07-15

blank

06

FDA Audited

USA
SCOPE Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
SCOPE Summit
Not Confirmed

Zhejiang Kangle Pharmaceutical

City : Wenzhou

State :

Country/Area : China

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2013-12-20

blank

07

FDA Audited

USA
SCOPE Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
SCOPE Summit
Not Confirmed

Zhejiang Kangle Pharmaceutical

City : Wenzhou

State :

Country/Area : China

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2009-04-23

blank
Contact Zhejiang Kangle Pharmaceutical and get a quotation

Zhejiang Kangle Pharmaceutical is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find a price of Paracetamol bulk with DMF, CEP, JDMF offered by Zhejiang Kangle Pharmaceutical

Find a price of Paracetamol bulk with DMF offered by Zhejiang Kangle Pharmaceutical

Find a price of Paracetamol bulk offered by Zhejiang Kangle Pharmaceutical

Find a price of Erdosteine bulk offered by Zhejiang Kangle Pharmaceutical